Poolbeg Pharma (POLB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

9.00p
   
  • Change Today:
      0.35p
  • 52 Week High: 9.20
  • 52 Week Low: 3.00
  • Currency: UK Pounds
  • Shares Issued: 763.44m
  • Volume: 2,656,063
  • Market Cap: £68.71m
  • Beta: 0.00

Deal with Barclays    Trade now with Barclays Stockbrokers

Latest ShareCast News

Director dealings: Poolbeg Pharma co-founder raise stake

By Iain Gilbert

Date: Wednesday 25 Jun 2025

(Sharecast News) - Poolbeg Pharma revealed on Wednesday that executive chair Cathal Friel had acquired 4.0m new ordinary shares in the AIM-listed biopharmaceuticals company.

Poolbeg Pharma extends cash runway after raising £4.87m

By Josh White

Date: Friday 23 May 2025

(Sharecast News) - Poolbeg Pharma announced on Friday that it has conditionally raised a total of £4.865m in gross proceeds through an upsized and oversubscribed BookBuild offer, placing, and subscription.

Poolbeg raises nearly £5m to progress clinical trials

By Benjamin Chiou

Date: Tuesday 20 May 2025

(Sharecast News) - Shares in biopharmaceutical group Poolbeg Pharma sank on Tuesday after the company revealed wider losses for the 2024 financial year as it raised nearly £5m in an oversubscribed placing as it progresses two key clinical trials.

Poolbeg shares slide as Hookipa terminates takeo... 21-Feb-2025 ShareCast
Poolbeg Pharma says Gilead in favour of its comb... 10-Jan-2025 ShareCast
Poolbeg Pharma granted new US patent 20-Nov-2024 ShareCast
Poolbeg agrees 12-month option over potential Be... 30-Apr-2024 ShareCast
Poolbeg Pharma to be granted US patent 20-Mar-2024 ShareCast
Director dealings: Poolbeg Pharma co-founder ups... 19-Feb-2024 ShareCast
Poolbeg upbeat on research into potential drug m... 12-Feb-2024 ShareCast
Poolbeg makes promising progress with RSV progra... 20-Dec-2023 ShareCast
Poolbeg gets notice of a new Japan patent 20-Sep-2023 ShareCast
Poolbeg reports progress with oral vaccine devel... 22-Jun-2023 ShareCast
Poolbeg expands its focus molecule into oncology 16-Jan-2023 ShareCast
Poolbeg identifies new drug candidates with OneT... 21-Dec-2022 ShareCast
Poolbeg secures exclusive licence to possible ob... 14-Dec-2022 ShareCast
Poolbeg announces 'breakthrough' in AI drug targ... 08-Nov-2022 ShareCast
Poolbeg Pharma upbeat on US patent application p... 04-Oct-2022 ShareCast
Poolbeg inks exclusive deal for melioidosis vacc... 21-Sep-2022 ShareCast
Poolbeg granted European patent for antiviral no... 14-Apr-2022 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Poolbeg Pharma Market Data

Currency UK Pounds
Share Price 9.00p
Change Today 0.35p
% Change 4.05 %
52 Week High 9.20
52 Week Low 3.00
Volume 2,656,063
Shares Issued 763.44m
Market Cap £68.71m
Beta 0.00

Poolbeg Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
53.79% below the market average53.79% below the market average53.79% below the market average53.79% below the market average53.79% below the market average
7.32% below the sector average7.32% below the sector average7.32% below the sector average7.32% below the sector average7.32% below the sector average
Price Trend
87.96% below the market average87.96% below the market average87.96% below the market average87.96% below the market average87.96% below the market average
77.27% below the sector average77.27% below the sector average77.27% below the sector average77.27% below the sector average77.27% below the sector average
Income Not Available
Growth Not Available

Poolbeg Pharma Dividends

No dividends found

Trades for 20-Aug-2026

Time Volume / Share Price
16:38 100,000 @ 8.90p
16:35 81,410 @ 9.00p
16:35 80,233 @ 9.00p
16:35 177 @ 9.00p
16:35 1,000 @ 9.00p

Poolbeg Pharma Key Personnel

CEO Jeremy Skillington
CFO Ian O’Connel

Top of Page